Metabolic Syndrome in Subjects with Type-2 Diabetes Mellitus

INTRODUCTION
The clustering of cardiovascular disease risk components found in persons with abnormal glucose tolerance (impaired glucose tolerance or diabetes mellitus) has been labeled variously as Syndrome X, the Insulin Resistance Syndrome, the Deadly Quartet, or metabolic syndrome (MS). The World Health Organization (WHO), has defined the syndrome to include a combination of impaired glucose regulation or diabetes, generic insulin resistance, raised arterial blood pressure, raised plasma triglycerides and/or low HDL-cholesterol, central obesity and/or BMI >30 kg nr2 and microalbuminuria. Each component of the cluster conveys increased cardiovascular disease risk, but as a combination they become much more powerful. This means that the management of persons with MS should focus not only on blood glucose control but also include strategies for reduction of the other cardiovascular disease risk factors. There is evidence that insulin drug resistance may be the common etiological factor for the individual components of the syndrome. Vigorous early management of the syndrome may have a significant impact on the prevention of both diabetes and cardiovascular disease.







This was a cross-sectional, descriptive study of adult outpatients who receive care at the family medicine clinic of an urban, academic health cen ter. A convenience sample of patients were given a self-administered exit survey, which included five items from the Patient Visit Rating Questionnaire (VRQ), in addition to items regarding specific chatting content areas and self-reported demographic information.


